An exploratory area of interest was quality of life (QOL). Additional PROs and Efficacy Data The FKSI-DRS and EORTC QLQ-C30 summary scores showed that there was not a significant change in symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback